Codes / ICD10CM / T64.02XS

T64.02XS Toxic effect of aflatoxin, intentional self-harm, sequela

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Toxic effect of aflatoxin, intentional self-harm, sequela

Summary

This condition represents the residual or chronic effects following intentional self-harm involving aflatoxin exposure. It is classified as a sequela, indicating long-term consequences of the initial toxic event. The effects may include persistent organ damage or ongoing health issues resulting from the prior intentional exposure to aflatoxin, a toxin produced by certain molds.

Causes

Intentional self-harm involving aflatoxin typically occurs through deliberate ingestion of contaminated food or substances. Aflatoxins are produced by fungi such as Aspergillus flavus and Aspergillus parasiticus, which contaminate crops like peanuts, corn, and grains. The sequela arises from the lasting impact of this prior exposure, which may have caused acute or chronic damage.

Risk Factors

  • Deliberate ingestion of aflatoxin-contaminated materials in the past.
  • History of intentional self-harm or underlying mental health conditions.
  • Prior exposure to high doses of aflatoxin, increasing the likelihood of residual effects.
  • Lack of timely or adequate treatment for the initial toxic event.

Symptoms

  • Persistent liver damage, such as cirrhosis or chronic hepatitis.
  • Ongoing fatigue, weight loss, or jaundice.
  • Reduced organ function or chronic health complications from the initial exposure.
  • Possible long-term neurological or systemic effects, depending on the severity of the prior toxicity.

Diagnosis

Diagnosis involves clinical evaluation of residual symptoms and a history of intentional aflatoxin exposure. Laboratory tests may assess liver function, organ damage, or toxin levels. Imaging or biopsies might be used to evaluate ongoing effects, and documentation of the prior self-harm event is essential for classification.

Treatment Options

Treatment focuses on managing residual symptoms and preventing further complications. This may include ongoing monitoring of organ function, supportive care for chronic conditions, and addressing any underlying health issues. Specific interventions depend on the affected organs and the severity of the sequela.

Prognosis and Follow-Up

Prognosis varies based on the extent of prior damage and the organs involved. Regular follow-up is often necessary to monitor for worsening symptoms or new complications. Long-term management may be required to address chronic health issues resulting from the initial exposure.

Complications

  • Progressive liver disease or organ failure.
  • Increased risk of secondary conditions, such as hepatocellular carcinoma.
  • Persistent fatigue or systemic health decline.
  • Psychological impacts related to the history of self-harm.

Lifestyle & Prevention

  • Avoid re-exposure to aflatoxin by ensuring food safety and proper storage.
  • Follow medical advice for managing chronic conditions resulting from the sequela.
  • Address mental health needs to reduce the risk of future self-harm.
  • Maintain regular health check-ups to monitor for complications.

When to Seek Professional Help

Seek medical attention if new or worsening symptoms occur, such as increased jaundice, severe fatigue, or signs of organ dysfunction. Prompt evaluation is important to address complications and adjust treatment as needed.

Tips for Medical Coders

This code is used for sequela of intentional self-harm due to aflatoxin toxicity. Document the history of the initial event, including intent and exposure details, to support the sequela classification. Ensure clear linkage between the prior toxic effect and the current residual condition.

Book a walkthrough

T64.02XS policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.